Managing AEs in Cabo Nivo Combination Therapy for Advanced R

Expert oncologists discuss the nuances of managing toxicities associated with Cabozantinib and Nivolumab combination therapy for advanced renal cell carcinoma (RCC).

Related Keywords

, Optimizing Therapy , Advanced Renal Cell Carcinoma , Cabo Nivo Combination Therapy , Renal Cell Carcinoma , Advanced Rcc , Metastatic Rcc , Kidney Cancer , Toxicity Management , Cabozantinib , Nivolumab , Drug Interactions , Organ Dysfunction , Adverse Events , Tyrosine Kinase Inhibitors , Clinical Trials , Treatment Strategies , Hepatotoxicity , Thrombosis , Anticoagulation , Dose Adjustments , Cardiomyopathy , Hand Foot Syndrome , Hypertension ,